No difference was observed in the lethality and body weight between AD mice treated with PBS vs. IFN-γ-iMSC-EVs, suggesting that IFN-γ-iMSC-EVs does not induce adverse effect in animals (Additional file 1: Fig. S2). This evidence concerns the gene IFNG and Alzheimer disease.